Enabling Global Participation in a Rare Disease Hybrid Study for Cerebral Adrenoleukodystrophy (CALD)
Posted | November 14, 2025The Challenge A global biopharmaceutical sponsor partnered with mdgroup to deliver a rare disease study focused on cerebral adrenoleukodystrophy (CALD). This rare manifestation of X-linked adrenoleukodystrophy (ALD) is a devastating…







